Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:dateCreated |
1993-11-16
|
pubmed:abstractText |
A human immunodeficiency virus (HIV) type 1-infected Hut-78 cell clone (F12) shows a peculiar phenotype: it exhibits an altered viral protein pattern, is a nonproducer and is resistant to homologous superinfection. To determine whether this phenotype is dependent upon the expression of the HIV-1 genome integrated therein, the SstI/SstI F12 provirus [deprived of HIV long terminal repeats (LTRs)] was cloned and inserted in the pLj retroviral vector bearing the neomycin (neo) and Geneticin resistance gene. CD4+ HIV-susceptible CEMss cells (a CEM clone able to form large syncytia 2 to 3 days post-HIV infection) were infected with the recombinant retroviruses rescued from the F12/HIV-pLj-transfected (in either sense or antisense orientation) amphotropic packaging cells PA 317. Neo sense resistant gene clones showed approximately 10 copies of viral DNA/cell (without detectable major deletions) only in episomal form, low viral RNA expression and a viral protein pattern characterized by an uncleaved gp160, no gp41 and little, if any, p55 gag precursor (as in F12 cells). Superinfection of these F12/HIV DNA-engineered clones with HIV-1 resulted in a significant reduction in the yield of superinfecting HIV. This effect (more pronounced when the clones were maintained under neo selective pressure) was observed in all five retrovirus-infected clones exhibiting the presence and expression of sense episomal F12/HIV DNA but not in two clones bearing an antisense F12/HIV DNA or in one clone bearing only the pLj vector. These results indicate that bio-engineered human CD4+ cells expressing the F12/HIV genome exhibit a significant resistance to HIV superinfection.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Oct
|
pubmed:issn |
0022-1317
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
74 ( Pt 10)
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
2099-110
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:8409934-Antigens, CD4,
pubmed-meshheading:8409934-Antigens, Viral,
pubmed-meshheading:8409934-Base Sequence,
pubmed-meshheading:8409934-Cells, Cultured,
pubmed-meshheading:8409934-Cloning, Molecular,
pubmed-meshheading:8409934-DNA, Viral,
pubmed-meshheading:8409934-Genetic Vectors,
pubmed-meshheading:8409934-HIV-1,
pubmed-meshheading:8409934-Humans,
pubmed-meshheading:8409934-Molecular Sequence Data,
pubmed-meshheading:8409934-Plasmids,
pubmed-meshheading:8409934-Polymerase Chain Reaction,
pubmed-meshheading:8409934-Recombinant Proteins,
pubmed-meshheading:8409934-Retroviridae,
pubmed-meshheading:8409934-Superinfection,
pubmed-meshheading:8409934-Transcription, Genetic,
pubmed-meshheading:8409934-Viral Interference
|
pubmed:year |
1993
|
pubmed:articleTitle |
A recombinant retrovirus carrying a non-producer human immunodeficiency virus (HIV) type 1 variant induces resistance to superinfecting HIV.
|
pubmed:affiliation |
Laboratory of Virology, Istituto Superiore di Sanità, Rome, Italy.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|